Have questions? Visit https://www.reddit.com/r/SNPedia

rs10868138

From SNPedia

Orientationplus
Stabilizedplus
Make rs10868138(C;C)
Make rs10868138(C;T)
Make rs10868138(T;T)
ReferenceGRCh38 38.1/141
Chromosome9
Position84302386
GeneSLC28A3
is asnp
is mentioned by
dbSNPrs10868138
ebirs10868138
HLIrs10868138
Exacrs10868138
Varsomers10868138
Maprs10868138
PheGenIrs10868138
hapmaprs10868138
1000 genomesrs10868138
hgdprs10868138
ensemblrs10868138
gopubmedrs10868138
geneviewrs10868138
scholarrs10868138
googlers10868138
pharmgkbrs10868138
gwascentralrs10868138
openSNPrs10868138
23andMers10868138
23andMe allrs10868138
SNP Nexus

SNPshotrs10868138
SNPdbers10868138
MSV3drs10868138
GWAS Ctlgrs10868138
GMAF0.1051
Max Magnitude
? (C;C) (C;T) (T;T) 28

[PMID 22118055] Single and combined IL28B, ITPA and SLC28A3 host genetic markers modulating response to anti-hepatitis C therapy


[PMID 21346688] Role of nucleoside transporters SLC28A2/3 and SLC29A1/2 genetics in ribavirin therapy: protection against anemia in patients with chronic hepatitis C.


GET Evidence
SLC28A3-Y113C
aa_change Tyr113Cys
aa_change_short Y113C
impact not reviewed
qualified_impact Insufficiently evaluated not reviewed
overall_frequency 0.110615
summary



[PMID 23195617] Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infection


[PMID 26071337] Role of ITPA and SLC28A2 genes in the prediction of anaemia associated with protease inhibitor plus ribavirin and peginterferon in hepatitis C treatment


[PMID 25661337] Role of pharmacogenetic in ribavirin outcome prediction and pharmacokinetics in an Italian cohort of HCV-1 and 4 patients